Fabien Calvo

29.0k total citations · 1 hit paper
160 papers, 6.7k citations indexed

About

Fabien Calvo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fabien Calvo has authored 160 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 63 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Fabien Calvo's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Protease and Inhibitor Mechanisms (12 papers) and Glycosylation and Glycoproteins Research (12 papers). Fabien Calvo is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Protease and Inhibitor Mechanisms (12 papers) and Glycosylation and Glycoproteins Research (12 papers). Fabien Calvo collaborates with scholars based in France, United States and Canada. Fabien Calvo's co-authors include Samia Mourah, M. Marty, Abdel‐Majid Khatib, Célèste Lebbé, Nathalie Scamuffa, Nabil G. Seidah, Eugène Sobngwi, Jean–François Gautier, Gustavo Linares‐Cruz and G. Millot and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Fabien Calvo

156 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

2015 369 citations Fabien Calvo et al. profile →

Peers

Countries citing papers authored by Fabien Calvo

Since Specialization

Citations

This map shows the geographic impact of Fabien Calvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Calvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Calvo more than expected).

Fields of papers citing papers by Fabien Calvo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Calvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Calvo. The network helps show where Fabien Calvo may publish in the future.

Co-authorship network of co-authors of Fabien Calvo

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Calvo. A scholar is included among the top collaborators of Fabien Calvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Calvo. Fabien Calvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients 2010 ·Clinical Cancer Research ·Delphine Kérob, Raphaël Porcher, O Vérola, Stéphane Dalle, E. Maubec, F. Aubin, M. D’Incan, (unknown), S. Boulinguez, Isabelle Madelaine‐Chambrin, A. Mathieu-Boué, Jean-Marie Servant, É. de Kerviler, Anne Janin, Fabien Calvo, Florence Pédeutour, Célèste Lebbé	98
2	Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes 2010 ·Journal of Experimental & Clinical Cancer Research ·Heriberto Bruzzoni‐Giovanelli, Plinio Fernández, (unknown), Marie-Pierre Podgorniak, Darren Powell, Marco M. Candeias, Samia Mourah, Fabien Calvo, Mónica Marı́n	20
3	Zebrafish ProVEGF-C Expression, Proteolytic Processing and Inhibitory Effect of Unprocessed ProVEGF-C during Fin Regeneration 2010 ·PLoS ONE ·Abdel‐Majid Khatib, Rachid Lahlil, Nathalie Scamuffa, Marie‐Andrée Akimenko, Sylvain Ernest, Abderrahim Lomri, Claude Lalou, Nabil G. Seidah, Bruno O. Villoutreix, Fabien Calvo, Géraldine Siegfried	19
4	Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors 2010 ·Cancer Immunology Immunotherapy ·Jaafar Bennouna, Vincent Lévy, Hélène Sicard, Hélène Senellart, Marie Audrain, Sandrine Hiret, Frédéric Rolland, Heriberto Bruzzoni‐Giovanelli, Marie Rimbert, (unknown), Jérôme Tiollier, Fabien Calvo	84
5	The antiapoptotic protein AAC‐11 interacts with and regulates Acinus‐mediated DNA fragmentation 2009 ·The EMBO Journal ·(unknown), (unknown), Audrey Faye, Jean‐Christophe Rain, Laurence Michel, Fabien Calvo, Jean‐Luc Poyet	61
6	EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2α–mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2 2009 ·Blood ·(unknown), Cathy Quemener, Sabrina Kellouche, Benyoussef Naïmi, Marie-Pierre Podgorniak, G. Millot, Éric Gabison, Fabien Calvo, Christine Dosquet, Célèste Lebbé, Suzanne Ménashi, Samia Mourah	95
7	Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7 2008 ·Gut ·Nathalie Scamuffa, Amit Basak, Claude Lalou, (unknown), Jadwiga Marcinkiewicz, Géraldine Siegfried, Michel Chrétien, Fabien Calvo, Nabil G. Seidah, Abdel‐Majid Khatib	27
8	VEGF and VEGFR‐1 are coexpressed by epithelial and stromal cells of renal cell carcinoma 2007 ·Cancer ·Jacqueline Rivet, Samia Mourah, Hideyuki Murata, Nicolas Mounier, (unknown), P. Mongiat-Artus, Pierre Teillac, Fabien Calvo, Anne Janin, Christine Dosquet	23
9	Inactivation of furin by its naturally occurring inhibitor pro-furin abolish breast cancer cells malignant phenotypes and tumorigenecity in mice. 2006 ·Cancer Research ·Nathalie Scamuffa, Nabil G. Seidah, Ajoy Basak, Fabien Calvo, Abdel‐Majid Khatib	1
10	Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers 2003 ·Journal of Vascular Surgery ·Patricia Senet, (unknown), M Benbunan, A Bussel, R Traineau, Fabien Calvo, Louis Dubertret, Christine Dosquet	116
11	SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway 2003 ·Oncogene ·Antonia Germani, (unknown), Samia Mourah, (unknown), Anna Di Carlo, Ricardo Ehrlich, Sylvie Gisselbrecht, Nadine Varin‐Blank, Fabien Calvo, Heriberto Bruzzoni‐Giovanelli	36
12	Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions 2001 ·The Journal of Pathology ·Lin Ma, Anne de Roquancourt, Philippe Bertheau, Sylvie Chevret, G. Millot, Xavier Sastre‐Garau, Marc Espié, Michel Marty, Anne Janin, Fabien Calvo	32
13	Confocal multilaser focusing and single-laser characterization of ultraviolet excitable stains of cellular preparations 2000 ·Cytometry ·Edmond Kahn, Frédérique Frouin, Catherine Souchier, (unknown), Heriberto Bruzzoni‐Giovanelli, (unknown), Guy Frija, R. Di Paola, Fabien Calvo, Gustavo Linares‐Cruz	10
14	Edema agudo hemorrágico del lactante: Presentación de 5 casos 1998 ·Anales de Pediatría ·(unknown), (unknown), (unknown), Fabien Calvo, (unknown)	2
15	Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): Evidence for an interaction between the two systems 1998 ·Journal of Cellular Biochemistry ·(unknown), Anastassia Hatzoglou, Fabien Calvo, Pierre-Marie Martin, Elias Castanas	12
16	Recent status of the antisense oligonucleotide approaches in oncology 1996 ·Fundamental and Clinical Pharmacology ·Lin Ma, Fabien Calvo	17
17	Recurrent cytogenetic alterations of prostate carcinoma and amplification of c‐myc or epidermal growth factor receptor in subclones of immortalized pnt1 human prostate epithelial cell line 1995 ·International Journal of Cancer ·Armelle Degeorges, Françoise Hoffschir, Olivier Cussenot, (unknown), Alain Le Duc, B. Dutrillaux, Fabien Calvo	45
18	Interferon‐γin vivo reverses the increased platelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasia 1991 ·British Journal of Haematology ·Marie‐Claire Martyré, H Magdelénat, Fabien Calvo	23
19	Increased intraplatelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasia 1991 ·British Journal of Haematology ·Marie‐Claire Martyré, H Magdelénat, Marijke Bryckaert, (unknown), Fabien Calvo	116
20	Phase I study of oxaliplatin in patients with advanced cancer 1990 ·Cancer Chemotherapy and Pharmacology ·Jean Marc Extra, Marc Espié, Fabien Calvo, Christophe Fermé, L. Mignot, M. Marty	295

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact